LIP
BMRN icon

Lighthouse Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Lighthouse Investment Partners’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$707K – 550
2025
Q1 		$707K Buy
+10,000
New +$673K 0.03% 365
2024
Q4 		– Sell
-20,000
Closed -$1.41M – 506
2024
Q3 		$1.41M Sell
20,000
-43,000
-68% -$3.59M 0.05% 300
2024
Q2 		$5.19M Buy
+63,000
New +$5.24M 0.21% 127
2024
Q1 		– Sell
-40,613
Closed -$3.92M – 385
2023
Q4 		$3.92M Buy
+40,613
New +$3.59M 0.18% 133

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lighthouse Investment Partners's BMRN Position: Q2 2025 in Review

Lighthouse Investment Partners sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 10,000 shares — an estimated $707K sold.

Lighthouse Investment Partners first reported a position in BMRN in Q4 2023 and held it in 4 quarters. The position peaked at $5.19M in Q2 2024. 581 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.

  • Lighthouse Investment Partners reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Lighthouse Investment Partners sold 10,000 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $707K.
  • Lighthouse Investment Partners first reported a position in BioMarin Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Lighthouse Investment Partners's BioMarin Pharmaceuticals position peaked at $5.19M in Q2 2024.
  • 581 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.

Based on Lighthouse Investment Partners's 13F filing for Q2 2025, filed 14 Aug 2025.